Lee, Ji Yeon http://orcid.org/0000-0002-2788-1392
Bu, Seon Hee http://orcid.org/0000-0002-5765-3358
Song, EunHyang http://orcid.org/0000-0002-7741-2113
Cho, Seongcheol http://orcid.org/0000-0002-5617-809X
Yu, Sungbong http://orcid.org/0000-0002-1989-6121
Kim, Jungok http://orcid.org/0000-0002-0694-1579
Kym, Sungmin http://orcid.org/0000-0003-3518-966X
Seo, Kwang Won http://orcid.org/0000-0003-0504-6924
Kwon, Ki Tae http://orcid.org/0000-0003-4666-0672
Kim, Jin Yong http://orcid.org/0000-0002-4306-1597
Kim, Sunghyun http://orcid.org/0000-0003-3898-0393
Ahn, Keumyoung http://orcid.org/0000-0002-9370-5338
Jung, Nahyun http://orcid.org/0009-0009-8639-4226
Lee, Yeonmi http://orcid.org/0000-0001-9657-6474
Jung, Yoobin http://orcid.org/0009-0002-8963-1476
Hwang, Chankyoung http://orcid.org/0009-0000-6567-4071
Park, Sang Won http://orcid.org/0000-0002-0550-1897
Funding for this research was provided by:
Celltrion
Article History
Received: 26 June 2023
Accepted: 15 August 2023
First Online: 13 October 2023
Declarations
:
: Ji Yeon Lee has been an investigator on COVID-19 clinical trials sponsored by Daewoong Pharmaceuticals, Hyundai Bioscience, Shin Poong Pharmaceutical, and Ildong Pharmaceutical and on an investigator-initiated trial with Celltrion Inc. Seongcheol Cho has been an investigator on a COVID-19 clinical trial sponsored by Shin Poong Pharmaceutical. Jungok Kim and Sungmin Kym have been investigators on COVID-19 trials sponsored by Daewoong Pharmaceuticals, Hyundai Bioscience, Shin Poon Pharmaceutical, Ildong Pharmaceutical, ImmuneMed, Bioleaders, Dong-Wha, Pfizer, Gilead, and Celltrion Inc. Ki Tae Kwon has been an investigator on COVID-19 clinical trials sponsored by GC Holdings, Pfizer, Hyundai Bioscience, APRG Inc., Shin Poong Pharmaceutical, and Ildong Pharmaceutical and on an investigator-initiated trial with Celltrion Inc. Jin Yong Kim has been an investigator on COVID-19 clinical trials sponsored by Daewoong Pharmaceuticals, Enzychem Lifesciences, GC Pharma, Bukwang Pharmaceutical and Pfizer outside the scope of the submitted work, and on an investigator-initiated trial with Celltrion Inc. Sunghyun Kim, Keumyoung Ahn, Nahyun Jung, Yeonmi Lee, Yoobin Jung, and Chankyoung Hwang are employees of Celltrion Inc. Seon Hee Bu, EunHyang Song, Sungbong Yu, and Kwang Won Seo declare no interests related to this article. Sang Won Park has been an investigator on a COVID-19 clinical trial sponsored by Celltrion Inc. Seon Hee Bu was affiliated with Seoul Metropolitan City Bukbu Hospital at the time of the study, and is now affiliated with Kyung Hee University Hospital.
: The study was conducted according to the ethical principles of the Declaration of Helsinki and in compliance with the International Council for Harmonisation Good Clinical Practice and applicable regulatory requirements. The study protocol was approved by the MFDS of the Republic of Korea. Per South Korean laws, additional approval from individual institutional review boards is not required for surveillance studies. All patients provided informed consent.